Ellen de Brabander

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Greenfield, IN
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
Dana Ng, Attorney-in-Fact
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Ellen de Brabander

Form 4 holding Executive Vice President, Research, Development and Regulatory Affairs

Elanco Animal Health Inc

Security class
Common Stock
Shares / value
280,821
Estimated value
$6,720,018
Report date
01 Apr 2026
Price
$23.93
Ownership
Direct
Form 4 holding Executive Vice President, Research, Development and Regulatory Affairs

Elanco Animal Health Inc

Security class
Employee Stock Option (right to buy)
Shares / value
51,819
Estimated value
Report date
01 Mar 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Ellen de Brabander

3 ELAN

Elanco Animal Health Inc

Report period
18 Oct 2021
Transactions
0
Transaction value
$0
Accepted by SEC
04 Nov 2021, 16:49
Role
Executive Vice President of Innovation and Regulatory Affairs; Exhibit List: Exhibit 24-Power of Attorney
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .